Print Issue: October 01, 2008

Sunitinib May Improve HRPC Therapy

STOCKHOLM—Sunitinib used in tandem with docetaxel and prednisone appears to be safe and well tolerated in men with metastatic hormone-refractory prostate cancer (HRPC), investigators announced here at the 33rd Congress of the European Society of Medical Oncology.

Many older individuals receive a false diagnosis of CKD stage 3, two nephrologists say.

CKD Staging Criteria Debated

Two nephrologists believe CKD is being overdiagnosed in the United States, particularly among the elderly. The physicians assert that the current National Kidney Foundation (NKF) Kidney Disease Outcome Initiative (K/DOQI) criteria for staging CKD include flaws, the most serious of which is the erroneous labeling of many elderly people as having CKD stage 3.

Less Regret Following Open PCa Surgery

Researchers who studied prostate cancer patients treated with either robot-assisted laparoscopic radical prostatectomy (RALP) or retropubic radical prostatectomy (RRP) found that RRP patients were less likely to be dissatisfied with their treatment choice.

Next post in Nephrology